DK0777669T3 - 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel - Google Patents
4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middelInfo
- Publication number
- DK0777669T3 DK0777669T3 DK95929954T DK95929954T DK0777669T3 DK 0777669 T3 DK0777669 T3 DK 0777669T3 DK 95929954 T DK95929954 T DK 95929954T DK 95929954 T DK95929954 T DK 95929954T DK 0777669 T3 DK0777669 T3 DK 0777669T3
- Authority
- DK
- Denmark
- Prior art keywords
- purin
- cyclopropylamino
- amino
- cyclopenten
- antiviral agent
- Prior art date
Links
- BOONDNCXQPMXQT-UHFFFAOYSA-N [4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;butanedioic acid Chemical compound OC(=O)CCC(O)=O.C=12N=CN(C3C=CC(CO)C3)C2=NC(N)=NC=1NC1CC1 BOONDNCXQPMXQT-UHFFFAOYSA-N 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 150000003890 succinate salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9417249A GB9417249D0 (en) | 1994-08-26 | 1994-08-26 | A novel salt |
| PCT/GB1995/002014 WO1996006844A1 (en) | 1994-08-26 | 1995-08-25 | 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0777669T3 true DK0777669T3 (da) | 2002-10-28 |
Family
ID=10760434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95929954T DK0777669T3 (da) | 1994-08-26 | 1995-08-25 | 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0777669B1 (da) |
| JP (1) | JPH10505593A (da) |
| KR (1) | KR100376240B1 (da) |
| CN (1) | CN1051550C (da) |
| AT (1) | ATE220067T1 (da) |
| AU (1) | AU702618B2 (da) |
| BR (1) | BR9508629A (da) |
| CA (1) | CA2198010C (da) |
| DE (1) | DE69527294T2 (da) |
| DK (1) | DK0777669T3 (da) |
| ES (1) | ES2179110T3 (da) |
| FI (1) | FI120403B (da) |
| GB (1) | GB9417249D0 (da) |
| HU (1) | HU221302B1 (da) |
| IL (1) | IL115074A (da) |
| MX (1) | MX9701273A (da) |
| NO (1) | NO315200B1 (da) |
| NZ (1) | NZ291862A (da) |
| PT (1) | PT777669E (da) |
| RU (1) | RU2145324C1 (da) |
| SI (1) | SI0777669T1 (da) |
| WO (1) | WO1996006844A1 (da) |
| ZA (1) | ZA957166B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9709945D0 (en) * | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
| AU7912398A (en) * | 1997-05-17 | 1998-12-11 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| AU8017298A (en) * | 1997-05-17 | 1998-12-11 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| CZ298144B6 (cs) * | 1997-11-27 | 2007-07-04 | Lonza Ag | Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu |
| GB9802472D0 (en) * | 1998-02-06 | 1998-04-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB9903091D0 (en) * | 1999-02-12 | 1999-03-31 | Glaxo Group Ltd | Therapeutic nucleoside compound |
| GB9918035D0 (en) * | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
| SK12822002A3 (sk) * | 2000-03-30 | 2003-02-04 | Bristol-Myers Squibb Company | Perličky s trvalým uvoľňovaním obsahujúce stavudín |
| ATE366569T1 (de) * | 2000-07-20 | 2007-08-15 | Lauras As | Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids |
| WO2003011221A2 (en) | 2001-07-30 | 2003-02-13 | University Of Southern California | PREPARATION AND USE OF α-KETO PHOSPHONATES |
| RU2242243C2 (ru) * | 2001-09-27 | 2004-12-20 | Вертелецкий Павел Васильевич | Композиции и способы потенцирования терапевтических эффектов интерферонов |
| ATE517622T1 (de) * | 2003-10-27 | 2011-08-15 | Merck Sharp & Dohme | Salz eines tetrahydropyranylcyclopentyltetrahydropyridopyr diderivats als ccr-2 antagonisten |
| EP1905772A1 (en) * | 2006-09-28 | 2008-04-02 | Esteve Quimica, S.A. | Process for the preparation of abacavir |
| EP2305680A3 (en) | 2009-09-30 | 2011-05-18 | Aurobindo Pharma Limited | Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol |
| WO2012137227A2 (en) | 2011-04-08 | 2012-10-11 | Laurus Labs Private Limited | Solid forms of antiretroviral compounds, process for the preparation and their pharmaceutical composition thereof |
| EP2962693B1 (en) | 2013-02-27 | 2019-01-09 | Kyoto University | Pharmaceutical composition comprising abacavir for the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3025492A1 (de) * | 1980-07-04 | 1982-02-04 | Siemens AG, 1000 Berlin und 8000 München | Filterelement fuer die optische nachrichtentechnik |
| SU1537138A3 (ru) * | 1982-02-01 | 1990-01-15 | Синтекс (Ю.С.А.) Инк (Фирма) | Способ получени производных пуринов или их солей |
| US5003462A (en) * | 1988-05-31 | 1991-03-26 | International Business Machines Corporation | Apparatus and method for implementing precise interrupts on a pipelined processor with multiple functional units with separate address translation interrupt means |
| GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| IL104283A (en) * | 1992-12-30 | 1996-12-05 | Agis Ind 1983 Ltd | Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate |
-
1994
- 1994-08-26 GB GB9417249A patent/GB9417249D0/en active Pending
-
1995
- 1995-08-25 AU AU33509/95A patent/AU702618B2/en not_active Expired
- 1995-08-25 RU RU97104483A patent/RU2145324C1/ru active
- 1995-08-25 ES ES95929954T patent/ES2179110T3/es not_active Expired - Lifetime
- 1995-08-25 SI SI9530614T patent/SI0777669T1/xx unknown
- 1995-08-25 ZA ZA9507166A patent/ZA957166B/xx unknown
- 1995-08-25 KR KR1019970701213A patent/KR100376240B1/ko not_active Expired - Lifetime
- 1995-08-25 BR BR9508629A patent/BR9508629A/pt not_active Application Discontinuation
- 1995-08-25 PT PT95929954T patent/PT777669E/pt unknown
- 1995-08-25 HU HU9701756A patent/HU221302B1/hu unknown
- 1995-08-25 DK DK95929954T patent/DK0777669T3/da active
- 1995-08-25 DE DE69527294T patent/DE69527294T2/de not_active Expired - Lifetime
- 1995-08-25 EP EP95929954A patent/EP0777669B1/en not_active Expired - Lifetime
- 1995-08-25 JP JP8508550A patent/JPH10505593A/ja active Pending
- 1995-08-25 AT AT95929954T patent/ATE220067T1/de active
- 1995-08-25 NZ NZ291862A patent/NZ291862A/en not_active IP Right Cessation
- 1995-08-25 IL IL11507495A patent/IL115074A/en not_active IP Right Cessation
- 1995-08-25 MX MX9701273A patent/MX9701273A/es active IP Right Grant
- 1995-08-25 WO PCT/GB1995/002014 patent/WO1996006844A1/en active IP Right Grant
- 1995-08-25 CA CA002198010A patent/CA2198010C/en not_active Expired - Lifetime
- 1995-08-25 CN CN95194789A patent/CN1051550C/zh not_active Expired - Lifetime
-
1997
- 1997-02-25 NO NO19970847A patent/NO315200B1/no not_active IP Right Cessation
- 1997-02-25 FI FI970786A patent/FI120403B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2198010C (en) | 2006-05-02 |
| NZ291862A (en) | 1998-02-26 |
| BR9508629A (pt) | 1997-11-25 |
| PT777669E (pt) | 2002-11-29 |
| CN1051550C (zh) | 2000-04-19 |
| CA2198010A1 (en) | 1996-03-07 |
| KR970705563A (ko) | 1997-10-09 |
| EP0777669A1 (en) | 1997-06-11 |
| ZA957166B (en) | 1997-02-25 |
| IL115074A0 (en) | 1995-12-08 |
| FI970786A0 (fi) | 1997-02-25 |
| HU221302B1 (en) | 2002-09-28 |
| EP0777669B1 (en) | 2002-07-03 |
| FI970786L (fi) | 1997-02-25 |
| NO970847L (no) | 1997-02-25 |
| CN1156456A (zh) | 1997-08-06 |
| AU702618B2 (en) | 1999-02-25 |
| NO970847D0 (no) | 1997-02-25 |
| NO315200B1 (no) | 2003-07-28 |
| ATE220067T1 (de) | 2002-07-15 |
| DE69527294D1 (en) | 2002-08-08 |
| DE69527294T2 (de) | 2003-02-13 |
| SI0777669T1 (en) | 2002-12-31 |
| KR100376240B1 (ko) | 2003-06-11 |
| JPH10505593A (ja) | 1998-06-02 |
| WO1996006844A1 (en) | 1996-03-07 |
| FI120403B (fi) | 2009-10-15 |
| RU2145324C1 (ru) | 2000-02-10 |
| IL115074A (en) | 1998-10-30 |
| ES2179110T3 (es) | 2003-01-16 |
| HUT77222A (hu) | 1998-03-02 |
| GB9417249D0 (en) | 1994-10-19 |
| AU3350995A (en) | 1996-03-22 |
| MX9701273A (es) | 1997-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0777669T3 (da) | 4-[2-amino-6-(cyclopropylamino)-9H-purin-yl]-2-cyclopenten-1-methanolsuccinat som antiviralt middel | |
| MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
| TW371660B (en) | Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections | |
| FI20001231A7 (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| CA2293470A1 (en) | Benzimidazole derivatives | |
| MY117892A (en) | Therapeutic compounds | |
| UA29429C2 (uk) | Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини | |
| MY104043A (en) | Therapeutic nucleosides. | |
| RU94002475A (ru) | Фармацевтическая композиция и ее применение для лечения вирусных инфекций | |
| TW371662B (en) | Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives | |
| HUP0002754A2 (hu) | (1S,4R)-cisz-4-[2-amino-6-(ciklopropil-amino)-9H-purin-9-il]-2-ciklopentén-1-metanol-hemiszulfát, eljárás előállítására, ezt tartalmazó gyógyszerkészítmény, valamint intermedierek | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| AU7806187A (en) | Sulphonamide derivatives for the treatment and prevention of viral diseases | |
| MY111746A (en) | Therapeutic nucleosides. | |
| AU6751794A (en) | Extracts of piliostigma thonningii, the use thereof and formulations containing them | |
| EP0459176A3 (en) | Oligophosphates with antiviral activity |